EverSource Wealth Advisors’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.13K Sell
31
-369
-92% -$41.8K ﹤0.01% 3377
2026
Q1
$44.5K Buy
400
+25
+7% +$2.96K ﹤0.01% 1988
2025
Q4
$50.6K Sell
375
-2
-0.5% -$218 ﹤0.01% 1741
2025
Q3
$32K Buy
377
+369
+4,613% +$22.6K ﹤0.01% 2015
2025
Q2
$61 Buy
+8
New +$52 ﹤0.01% 4176

Other funds holding ABVX

EverSource Wealth Advisors's ABVX Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Abivax (ABVX) stake by 92% in Q2 2026, selling an estimated $41.8K and leaving 31 shares worth $4.13K. The position accounts for ﹤0.01% of the portfolio, ranked #3377.

EverSource Wealth Advisors first reported a position in ABVX in Q2 2025 and has held it in 5 quarters since. The position peaked at $50.6K in Q4 2025. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • EverSource Wealth Advisors held 31 shares of Abivax worth $4.13K as of Q2 2026.
  • EverSource Wealth Advisors sold 369 Abivax shares in Q2 2026, an estimated $41.8K.
  • Abivax made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3377 holding.
  • EverSource Wealth Advisors first reported a position in Abivax in Q2 2025 and has held it in 5 quarters since.
  • EverSource Wealth Advisors's Abivax position peaked at $50.6K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.